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Pathological conversion of 
regulatory T cells is associated with 
loss of allotolerance
Jing Hua1, Takenori Inomata  1, Yihe Chen1, William Foulsham  1, William Stevenson1,  
Tina Shiang1, Jeffrey A. Bluestone2 & Reza Dana1
CD4+CD25+Foxp3+ Regulatory T cells (Tregs) play a critical role in immune tolerance. The plasticity 
and functional adaptability of Tregs in an inflammatory microenvironment has been demonstrated 
in autoimmunity. Here, using a double transgenic mouse model that permits Foxp3 lineage tracing, 
we investigated the phenotypic plasticity of Foxp3+ Tregs in a well-characterized murine model of 
corneal transplantation. In order to subvert the normal immune privilege of the cornea and foster 
an inflammatory milieu, host mice were exposed to desiccating stress prior to transplantation. Treg 
frequencies and function were decreased following desiccating stress, and this corresponded to 
decreased graft survival. A fraction of Tregs converted to IL-17+ or IFNγ+ ‘exFoxp3’ T cells that were 
phenotypically indistinguishable from effector Th17 or Th1 cells, respectively. We investigated how 
Foxp3 expression is modulated in different Treg subsets, demonstrating that neuropilin-1− peripherally-
derived Tregs are particularly susceptible to conversion to IL-17+/IFNγ+ exFoxp3 cells in response 
to cues from their microenvironment. Finally, we show that IL-6 and IL-23 are implicated in the 
conversion of Tregs to exFoxp3 cells. This report demonstrates that the pathological conversion of Tregs 
contributes to the loss of corneal immune privilege.
CD4+CD25+Foxp3+ regulatory T cells (Tregs) play a critical role in mediating immunological self-tolerance. 
Thymus-derived tTregs, and their peripherally induced counterparts pTregs, provide essential suppressive mech-
anisms against deleterious immune-mediated inflammation. These specialized T cell subsets are clonal groupings 
within a much larger, heterogeneous population of CD4+ T cells – including Th1, Th2 and Th17 cells. Previously 
believed to perform discrete and permanent functions defined by specific cytokine profiles, there is mounting 
evidence that these CD4+ T cell subsets exhibit marked phenotypic plasticity, repolarizing towards mixed or 
alternative fates according to cues from their microenvironments1,2.
Treg plasticity has been widely observed in autoimmune conditions, such as type 1 diabetes, juvenile arthritis 
and multiple sclerosis1. Decreased stability of Foxp3 expression and increased proportions of Th1-like IFNγ+ 
Tregs have been found in these conditions3–5. The reprogramming of Tregs towards a memory T cell phenotype 
has been shown to promote inflammation in autoimmune disease6. However, there is limited knowledge about 
Treg plasticity in the context of transplantation.
Tregs play an essential role in the induction and maintenance of tolerance to alloantigens7,8. Tregs promote 
graft acceptance by suppressing host immunity against transplants. Levels of Foxp3 expression have been shown 
to be vitally important for the suppressor function of Tregs9,10. In a murine model of corneal transplantation, 
Foxp3 expression by Tregs has been demonstrated to be more reflective of allograft outcome than Treg absolute 
frequencies11. Still, we do not know whether the inflammatory milieu following tissue grafting provokes repro-
gramming of Tregs; and, if so, whether loss of Foxp3 expression can cause allorejection.
In this study, using a double transgenic mouse model that permits Foxp3 lineage tracing, we investigated the 
phenotypic plasticity of Foxp3+ Tregs in a well-characterized murine model of corneal transplantation12–14. We 
demonstrate that inflammation in the ocular tissue leads to the loss of Foxp3 in Tregs, and their conversion to 
‘exFoxp3 cells’, which express the pro-inflammatory cytokines IL-17 and/or IFN-γ. Through adoptive transfer of 
Treg subsets, we show that neuropilin-1− pTregs are highly susceptible to environmental cues that promote their 
1Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard 
Medical School, Boston, MA, USA. 2Diabetes Center, University of California San Francisco, San Francisco, CA, USA. 
Correspondence and requests for materials should be addressed to R.D. (email: Reza_Dana@meei.harvard.edu)
Received: 5 January 2018
Accepted: 11 April 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific REPORTS |  (2018) 8:7059  | DOI:10.1038/s41598-018-25384-x
conversion to exFoxp3 cells. These results provide evidence that pathological conversion of Tregs contributes to 
the loss of corneal immune privilege and allograft rejection.
Results
Dry eye disease in corneal transplant recipients limits allograft survival, and decreases the fre-
quencies and function of Tregs. In corneal transplantation, completely mismatched allografts have a long-
term survival rate of 50% without any local or systemic treatment. However, local inflammation at the transplant 
site (of which dry eye disease is the most common cause15) often jeopardizes graft survival16. We first performed 
allogeneic corneal transplantation in healthy or DED recipients. Our results demonstrated that induction of DED 
in graft recipients before performing corneal transplantation resulted in significantly higher graft opacity scores 
compared to healthy hosts (Fig. 1A). Furthermore, graft survival decreased from 60% in healthy recipients to 10% 
in dry eye hosts at week 8 after transplantation (Fig. 1B). Next, we analyzed the frequencies of CD4+CD25+ Tregs 
and the capacity of Tregs to suppress CD4+ CD25− T cell proliferation in dry eye and healthy graft recipients, and 
found that both frequencies (Fig. 1C) and suppressive function (Fig. 1D) of Tregs were significantly suppressed in 
hosts with dry eye compared to healthy controls.
Dry eye disease in corneal transplant recipients increases frequencies of exFoxp3 cells. It has 
been shown that inflammation affects Foxp3 expression in Tregs, and therefore conveys their lineage and func-
tional instability6. To investigate Treg plasticity in corneal transplantation, we employed transgenic reporter mice 
that carry a Foxp3 lineage reporter gene construct6,17, in which we could trace Foxp3 expression and its loss in 
Tregs. In these mice, Tregs that express or used to express Foxp3 are RFP+. Tregs that currently express Foxp3 are 
GFP+, but loss of Foxp3 expression results in these cells becoming GFP−. Thus, these ‘exFoxp3 cells’ can easily be 
distinguished from functional Tregs (Tregs = GFP+RFP+, exFoxp3 cells = GFP−RFP+).
We performed corneal transplantation in healthy and DED hosts and analyzed their frequencies of GFP−RFP+ 
exFoxp3 cells in draining lymph nodes (dLN) at 2 weeks following transplantation. Our previous work has indi-
cated that this is the optimum time point to evaluate the alloimmune response prior to the onset of higher rejec-
tion frequencies, which occur at week 311,13,14,16,18. Importantly, although we did not observe clinically visible 
rejection at week 2, we found significantly higher exFoxp3 frequencies in dLN of dry eye hosts compared to 
healthy recipients (Fig. 2A and B). Our analysis of the inflammatory cytokine expression by these exFoxp3 cells 
revealed increased frequencies of IFN-γ+ exFoxp3 cells in both dLN and ocular surface in DED hosts relative to 
control recipients (Fig. 2C,D and E). IFN-γ-producing CD4+ T cells (Th1 cells) are the principal effector cells in 
Figure 1. Dry eye disease reduces graft survival and Treg function after allograft survival. Healthy corneal 
grafts were transplanted on normal control hosts or dry eye (DED) hosts. (A) Corneal graft opacity 
(***p < 0.001) and (B) graft survival were assessed for 8 weeks (n = 10/group, **p < 0.01). Draining lymph 
nodes were harvested 2 weeks post-transplantation. Single cell suspensions were analyzed by flow cytometry. 
(C) Frequencies of CD4+Foxp3+ Tregs from control vs. DED hosts was determined using flow cytometry (n = 5 
and ***p < 0.001) (D) Treg suppression assay (n = 6) was performed using CD4+CD25− responders from 
rejected control hosts, and CD4+CD25+Tregs from control and dry eye hosts (**p < 0.01). Data is presented as 
mean ± SEM (error bar).
www.nature.com/scientificreports/
3Scientific REPORTS |  (2018) 8:7059  | DOI:10.1038/s41598-018-25384-x
corneal allograft rejection19; thus, the observed higher frequencies of IFN-γ+ exFoxp3 cells in DED hosts may 
contribute to higher graft rejection rates in these recipients.
Adoptively transferred pTregs are susceptible to conversion to exFoxp3 cells in DED hosts and 
fail to improve graft survival. To investigate the plasticity of pTregs and tTregs in the context of corneal 
transplantation, we adoptively transferred Foxp3-GFP×R26-RFP transgenic Nrp-1− pTregs and Nrp-1+ tTregs 
into wild-type control and DED hosts at the time of surgery. Two weeks later, the phenotype of these transferred 
cells was assessed in dLN using flow cytometry. The frequencies of exFoxp3 (GFP−RFP+) cells were significantly 
increased when pTregs were adoptively transferred to DED hosts compared to control hosts (Fig. 3A), suggest-
ing that the inflammatory microenvironment in DED hosts enhanced loss of Foxp3 expression and promoted 
exFoxp3 formation. However, in the tTreg-transferred mice, no difference was seen in the frequencies of exFoxp3 
cells (Fig. 3B). When analyzing the inflammatory cytokine profile of transferred pTregs, we found that the pop-
ulation of Tregs that did not express inflammatory cytokines (i.e. IFN-γ−IL-17−) was significantly reduced in 
DED hosts relative to control hosts (20.5% and 54.5%, respectively) (Fig. 3C). In contrast, the difference between 
the populations of IFN-γ−IL-17− Tregs in DED hosts and control hosts following adoptive transfer of tTregs was 
negligible (56.9% and 51.9%, respectively). Superior corneal allograft survival in hosts receiving adoptive transfer 
of isolated allosensitized pTregs compared to tTregs has previously been established13. To investigate whether 
the same phenomenon would be observed in DED hosts, we adoptively transferred isolated allosensitized tTregs 
and pTregs from hosts with accepted allografts to DED hosts receiving fresh allografts. Transfer of pTregs into 
DED hosts did not confer additional protection from allorejection compared to tTregs (Fig. 3D). These data sug-
gest that the DED microenvironment compromises both the phenotypical and functional stability of transferred 
pTregs.
Increased graft rejection observed in DED hosts is mediated via IL-6 and IL-23. IL-6 and IL-23 
signaling are known to play an important role in Treg function20–22. In order to evaluate the potential immuno-
modulation of pTregs and tTregs by IL-6 and IL-23, we examined IL-6 and IL-23 receptor expression by these 
Treg subsets using flow cytometry. We found that pTregs in DED hosts expressed higher levels of both IL-6R and 
IL-23R compared to pTregs in control hosts. In contrast, tTregs expressed comparable levels of these receptors 
Figure 2. Dry eye disease promotes loss of Foxp3 expression by Tregs following corneal transplantation. Foxp3-
GFP-CreXR26-RFP transgenic mice were used to trace Foxp3 expression after transplantation. Healthy corneal 
grafts were transplanted onto transgenic naïve control hosts or dry eye (DED) hosts. Draining lymph nodes 
were harvested 2 weeks post-transplantation. Single cell suspensions were analyzed by flow cytometry. (A) 
Representative flow cytometry plots and (B) statistical analysis of flow cytometry data showing frequencies of 
exFoxp3 cells in Foxp3-GFPXR26-RFP control and DED hosts (n = 6/group, ***p < 0.001). (C) Representative 
flow cytometry plots and (D, E) statistical analyses of flow cytometry data showing frequencies of exFoxp3 
cells that express IFNγ (***p < 0.001) and IL-17 (**p < 0.01) in Foxp3-GFPXR26-RFP control and DED hosts 
(n = 6/group). Data is presented as mean ± SEM (error bar).
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in both DED and control hosts (Fig. 4A). Elevated expression of IL-6 and IL-23 has been reported in DED23,24. 
In this study, we also found increased expression of both IL-6 and IL-23 in dLNs of DED hosts (Fig. 4B). To 
determine the effects of IL-6 and IL-23 in vivo, we neutralized these cytokines in DED hosts by intraperitoneal 
injection of IL-6 and IL-23 neutralizing antibodies, and evaluated allograft survival. Interestingly, while neutrali-
zation of IL-6 and IL-23 promoted transplant survival, this approach failed to rescue all transplants in DED hosts 
(Fig. 4C). To investigate whether both pTregs and stabilizing the microenvironment might establish allotolerance, 
we adoptively transferred allosensitized pTregs to DED hosts in addition to IL-6 and IL-23 neutralization. This 
strategy significantly improved graft survival up to 90% (Fig. 4D), suggesting that IL-6 and IL-23 may impede the 
induction and stability of pTregs, thereby disrupting allotolerance.
Discussion
By subverting the normal immune privilege of the cornea with desiccating stress prior to transplantation, an 
inflammatory milieu is created in which allograft survival is jeopardized. Our data demonstrate that Treg fre-
quencies and function are reduced in this setting, and that this corresponds to decreased graft survival. We show 
that a fraction of Tregs loses Foxp3 expression entirely, becoming IL-17+ or IFNγ+ exFoxp3 cells that are phe-
notypically indistinguishable from effector Th17 or Th1 cells, respectively. We investigate the stability of Foxp3 
expression in different Treg subsets, demonstrating that neuropilin-1− pTregs are particularly liable to conversion 
to exFoxp3 cells in response to cues from their microenvironment. Finally, we show that exposure to desiccating 
stress increases the expression of IL-6 and IL-23 in the dLNs of corneal allograft recipients, and that neutralization 
of these cytokines promotes transplant survival.
The breadth of CD4+ T cell subsets has widened over the past two decades, from the long-established Th1 and 
Th2 subsets, to a much broader grouping including Th9, Th17, T follicular helper cells, tTregs and pTregs. The 
evolving paradigm of T cell phenotypic plasticity is based on the hypothesis that these subsets are not fixed, and 
that T cell subsets can repolarize towards alternative fates in response to environmental changes1. Consistent with 
this paradigm, there is an increasing body of evidence that the Foxp3+ Treg lineage is unstable in vivo25. Moreover, 
a number of murine studies involving the adoptive transfer of exFoxp3 cells have demonstrated their pathogenic-
ity – specifically their ability to induce experimental autoimmune encephalitis26, type 1 diabetes6, arthritis27, 
Figure 3. pTregs show a higher susceptibility to convert into exFoxp3 cells after transfer into dry eye hosts. 
pTregs (CD4+CD25+Nrp-1−) and tTregs (CD4+CD25+Nrp-1+) from transgenic dry eye disease (DED) mice 
(Foxp3-GFP×R26-RFP) were adoptively transferred into control and DED transplant recipients. (A and B) 
Draining lymph nodes were harvested at day 14 post-transplantation. Single cell suspensions were analyzed by 
flow cytometry. Frequencies of exFoxp3 cells (GFP−RFP+) from control and DED hosts that received (A) pTregs 
(59.02 ± 0.92% vs. 78.26 ± 0.69%, n = 4, ***p < 0.0001 unpaired two-tailed Student’s t test) or (B) tTregs was 
assessed. (C) Representative flow cytometry plots showing frequencies of IL-17 and IFNγ-expressing exFoxp3 
cells in draining lymph nodes from control and dry eye hosts. (D) Nrp1+ tTregs or Nrp1− pTregs from hosts 
with accepted allografts were adoptively transferred to dry eye hosts, and graft survival was assessed for 8 weeks 
(n = 10, χ2 = 0.6087, p = 0.4353).
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colitis28 as well as lung and liver inflammation29. Our data further substantiate the pathogenicity of exFoxp3 cells 
and illustrate their relevance to transplantation immunology.
The prospect of Treg-mediated immunotherapy is the focus of considerable attention30–33. In transplanta-
tion, strategies to clonally expand Tregs are being explored, in which the suppressive activity of Tregs might be 
exploited to induce graft tolerance34. In the setting of murine corneal transplantation, treatment with low-dose 
IL-2 has been shown to expand the population of Tregs in vivo and increase their immunosuppressive function, 
resulting in prolonged allograft survival18. With Treg-based immunotherapy on the horizon, there is a pressing 
requirement for clear definitions of Treg subsets, as well as an understanding of the factors that control Treg 
plasticity. pTregs have been shown to constitute a significant portion of Tregs in the periphery, particularly at 
mucosal tissues35. There is an increasing body of evidence demonstrating that pTregs have a vital and unique 
role, distinct from tTregs, in maintaining immune homeostasis at these sites36–38. There are some important dif-
ferences in the mechanisms of action of tTregs and pTregs, with polyclonal tTregs modulating Th1 trafficking, 
and antigen-specific pTregs preventing T-cell priming by controlling the expression of MARCH1 and CD83 on 
dendritic cells39.
Previously, we have shown that tTregs and pTregs have different capacities to promote corneal graft accept-
ance in high-risk (inflamed and vascularized) host beds13. Specifically, we have demonstrated that pTregs from 
Figure 4. Blockade of IL-6 and IL-23 promotes allograft survival. Draining lymph nodes were harvested 2 
weeks post-transplantation. Single cell suspensions were analyzed by flow cytometry. (A) Flow cytometry 
analysis of IL-6R and IL-23R expression by Nrp1+ tTregs and Nrp1−pTregs from draining lymph nodes 
of control and DED hosts. (B) ELISA analysis showing IL-6 and IL-23 protein levels in the supernatant of 
explanted draining lymph nodes of healthy control and dry eye (DED) hosts (n = 4, p = 0.0015 and 0.0086, 
respectively; unpaired two-tailed Student’s t-test). (C) Allograft survival of DED hosts treated with anti-IL-6 and 
anti-IL-23 antibodies or isotype-treated control hosts are shown (n = 10, χ2 = 4.525, *p = 0.0334, Log-Rank). 
(D) Allograft survival in DED hosts treated with anti-IL-6 and anti-IL-23 and adoptively transferred with Nrp-
1+ or Nrp-1− Tregs (n = 10, χ2 = 4.503, *p = 0.0338, Log-Rank). Data is presented as mean ± SEM (error bar).
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high-risk hosts are reduced in both frequency and function, which correlated with reduced expression of CTLA-
4, IL-10 and transforming growth factor-β13. Our new data corroborate these findings and provide novel insights 
into the fate of pTregs in transplantation. Here, we show that transfer of pTregs in an inflamed DED host bed 
results in a significant increase in frequencies of exFoxp3 cells relative to a healthy uninflamed control host bed 
- a finding that was not observed in experiments involving the adoptive transfer of tTregs. The level of DNA 
methylation at Treg-specific demethylated region (TSDR) of the Foxp3 locus has been shown to reflect reduced 
stability of Foxp3 expression40. Furthermore, neuropilin-1− pTregs have been shown to have a higher degree of 
methylation at the TSDR relative to neuropilin-1+ tTregs, corresponding to decreased stability of Foxp3 expres-
sion41. Our findings are consistent with these observations, suggesting that an inflammatory microenvironment 
subverts the immunoregulatory capacity of pTregs, with a concomitant loss of Foxp3 expression and conversion 
to exFoxp3 cells.
Tregs with decreased expression of Foxp3 produce high levels of IL-1742, a key cytokine in the pathogene-
sis of autoimmunity43. The interconnected differentiation pathways of Treg and Th17 cells have previously been 
demonstrated; either subset can develop from FoxP3-RORγt double-positive CD4+ T cells depending on signa-
ling from pro-inflammatory cytokines44,45. In particular, IL-6 and IL-23 have been shown to have critical roles in 
altering the balance between Treg and Th17 responses, and can in fact restrain Treg function20–22,46. Elevated levels 
of IL-6 and IL-23 have previously been demonstrated in both murine models of DED and in case-control stud-
ies23,47. Furthermore, Treg dysfunction has been reported in the recipients of corneal allografts from mice previously 
exposed to desiccating stress, suggesting that the Th17-driven inflammatory microenvironment of DED may com-
promise Treg stability48. The accumulating data implicating Th17-associated cytokines in Treg plasticity prompted 
us to examine IL-6 and IL-23 cytokine receptor expression of pTregs and tTregs. Our data show that pTregs in DED 
hosts express higher levels of both IL-6R and IL-23R relative to tTregs in control hosts. In contrast, tTregs express 
comparable levels of these receptors in both DED and control hosts. These data illustrate that pTregs have a higher 
sensitivity than tTregs to IL-6 and IL-23 in an inflamed setting, which may account for their greater propensity 
for pathological conversion to the exFoxp3 phenotype. By demonstrating a 90% graft survival rate with adoptive 
transfer of allosensitized pTregs in addition to IL-6 and IL-23 neutralization, we show clearly that modulating the 
cytokine microenvironment can be an effective strategy to counter the pathological Treg conversion.
In view of the plasticity of Foxp3 expression, it has previously been suggested that a fraction of pathogenic 
exFoxp3 cells may subsequently revert back to stable Tregs2. It is important to note that our lineage-tracing 
mouse model does not permit differentiation between exFoxp3 cells that have regained Foxp3 expression and 
Foxp3+ Tregs, since both subsets would be GFP+RFP+. Previous studies using the Foxp3-GFP-Cre-R26-RFP 
mouse model suggest that cells that transiently express Foxp3 represent a small percentage of the exFoxp3 popu-
lation, with the majority of exFoxp3 cells being derived from Treg cells with ‘signature’ features (Foxp3hi, CD25hi, 
demethylated TSDR)26,49.
In summary, this study provides novel insights into Treg phenotypic plasticity in transplantation. By demon-
strating increased conversion to exFoxp3 cells in an inflamed host bed, we establish that Treg plasticity in corneal 
transplantation is moderated by the surrounding microenvironment. Our data show that neuropilin-1− pTregs 
are particularly prone to conversion to exFoxp3 cells in hosts previously exposed to desiccating stress. We estab-
lish that manipulation of Th17-associated cytokines provides a viable method of fostering graft survival in this 
setting. Further characterization of the cytokine cues that regulate Treg plasticity will provide immunoregulatory 
strategies for inducing transplantation tolerance.
Material and Methods
Animals. Eight- to 10-week old Balb/c and C57/BL6 were purchased from Charles River Laboratories 
(Wilmington, MA). We crossed transgenic mice expressing a green fluorescent protein–Cre recombinase fusion 
protein (GFP-Cre) controlled by the Foxp3 promoter on a bacterial artificial chromosome (BAC; Foxp3-GFP-
Cre)50 and a Rosa26-loxP-Stop-loxP-RFP (R26-RFP) construct-carrying line17,51 to generate Foxp3-GFP-Cre-
R26-RFP mice. The R26-RFP carrying line was a generous gift from Dr. Hans-Joerg Fehling from the Institute 
of Immunology, University Ulm, Germany. Mice were housed in a secure, pathogen-free environment in the 
Schepens Eye Research Institute Animal Facility. All animals were treated in accordance with the Association 
for Research in Vision and Ophthalmology (ARVO) statement for the Use of Animals in Ophthalmic and 
Vision Research, and all experiments were approved by the Institutional Animal Care and Use Committee of the 
Schepens Eye Research Institute.
Induction of dry eye disease. We induced dry eye disease (DED) by housing mice in a controlled envi-
ronment chamber for 14 days, as described previously52. Briefly, the chamber allows a continuous regulation 
and maintenance of the temperature (21–23 °C), relative humidity (10–15%), and airflow (15 L/min). Age- and 
gender-matched control mice were housed in normal environment of the animal facility. During the course of 
DED induction, we utilized corneal fluorescein staining and the National Institute of Health grading system (NEI, 
Bethesda, MD) to evaluate corneal epithelial damage caused by desiccating stress53. Fourteen days after DED 
induction, we performed the transplantation procedure, as described below.
Corneal transplantation and assessment of graft survival. Murine orthotopic corneal transplanta-
tion was performed, as previously described54. Briefly, a 2-mm central cornea button was excised from a donor 
mouse; similarly, a 1.5 mm central cornea button was excised from a DED or control (room air) recipient mouse 
(wild-type BALB/c or transgenic). The donor graft was then secured to the recipient bed with eight interrupted 
11–0 nylon sutures (Surgical Specialties Co., Reading, PA). Animals were monitored every 10–15 minutes intra-
operatively, and 6, 24, and 72 hours postoperatively for signs of distress. The surgical procedures were performed 
under anesthesia using intraperitoneal ketamine (120 mg/kg bodyweight) and xylazine (20 mg/kg bodyweight). In 
www.nature.com/scientificreports/
7Scientific REPORTS |  (2018) 8:7059  | DOI:10.1038/s41598-018-25384-x
addition, subcutaneous buprenorphine (0.1 mg/kg bodyweight) was given intraoperatively and every 8–12 hours 
up to 48 hours postoperatively to reduce pain. The sutures were removed 7 days post-transplantation. After cor-
neal transplantation, graft survival and opacity were evaluated in a masked fashion weekly for up to 8 weeks using 
slit lamp biomicroscopy according to a standard opacity-grading system55. Grafts with an opacity score of 2 or 
greater for two consecutive follow-ups were considered as rejected.
Slit lamp eye examination. Induction of dry eye was confirmed by measuring disruption in the corneal 
epithelial integrity using corneal fluorescein staining. We applied 0.7 μl of 2.5% fluorescein to the lateral conjunc-
tival sac of the mice; two minutes later, eyes were examined for fluorescein staining with a slit lamp biomicroscope 
under cobalt blue light. Punctate staining was recorded in a masked fashion using the standard National Eye 
Institute grading system giving a score from 0 to 3 for each of the five areas of the cornea53.
In vivo cytokine neutralization. Lyophilized rat anti-mouse IL-6 and IL-23 neutralizing antibodies and 
isotype controls (Biolegend, San Diego, CA) were resuspended in PBS to yield a concentration of 1 µg/µl. 100 µg 
anti-IL-6 and 100 µg anti-IL-23 or isotype controls were administered by intraperitoneal injections every other 
day for 14 days starting from the day of transplantation. To analyze Treg frequencies, mice were euthanized at day 
14, and tissue samples were harvested for further analysis. To determine the effect of IL-6 and IL-23 neutralization 
on graft survival, mice were treated every other day for 14 days and then every 5 days until day 56, and euthanized 
thereafter.
Flow cytometry. Ipsilateral cervical and submandibular draining lymph nodes and corneas were collected from 
graft recipients 14 days after transplantation and single cell suspensions were prepared, as previously described56. 
In brief, corneas were digested in RPMI media (Lonza, Walkersville, MD) containing 2 mg/ml collagenase type IV 
(Sigma-Aldrich, St. Louis, MO) and 2 mg/ml DNase I (Roche, Basel, Switzerland) for 60 min at 37 °C, and then fil-
tered through a 70-μm cell strainer. Collected lymph nodes were homogenized in 70-μm cell strainers and single cell 
suspensions were prepared. Cell suspensions were then washed in fluorescent activated cell sorting (FACS) buffer 
(2.5% BSA in PBS) and incubated with an anti-Fc-receptor blocking antibody (Clone 91; eBioscience,) to avoid 
non-specific staining. The following monoclonal antibodies were purchased from BioLegend unless noted other-
wise: anti-mouse CD4 (RM4-5), CD25 (PC61), Foxp3 (FJK-16s), IFN-γ (XMG1.2) IL-17A (TC11-18H10.1), Nrp-1 
(Clone FAB566N; R&D Systems), IL-6R (D7715A7), and IL-23R (Clone 753317; R&D Systems). For intracellular 
IL-17A and IFN-γ staining, cells were stimulated in cell culture medium (BD Bioscience) with phorbol 12-myristate 
13-acetate (PMA) 50 ng/ml−1 and Ionomycin 500 ng/ml−1 (Sigma-Aldrich) for 4 hours in the presence of protein 
transport inhibitor (GolgiStopTM). After washing, cells were first stained for surface antigens and then fixed and per-
meabilized (IC Fixation Buffer and Permeabilization Buffer, eBioscience) before intracellular staining. For intracel-
lular Foxp3 staining, the Foxp3 Staining Buffer Set (Cat. # 00-5523, eBioscience) was used. Isotype-matched control 
antibodies were used in all experiments. Finally, cells were analyzed by an LSRII flow cytometer (Beckman Coulter), 
and data were analyzed using FlowJo software X 10.0.7 (Tree Star Inc.).
Ex vivo Treg suppression assay. Responder CD4+CD25− T (Tresp) cells were isolated from the dLNs of 
naïve BALB/c mice using a CD4 T cell isolation kit (Cat. #130-104-454, Miltenyi Biotec), and allogeneic anti-
gen presenting cells (APCs) were isolated from the spleen of naïve C57BL/6 mice by depleting T cells using 
a CD90.2 isolation kit (Cat. #130-049-101, Miltenyi Biotec). CD4+CD25+ Tregs were isolated from dLNs of 
recipients 14 days after transplantation using a commercially available isolation kit (Cat. #130-091-041, Miltenyi 
Biotec). The phenotype of sorted Tregs was confirmed by assessing their expression of Foxp3 using flow cytome-
try (purity > 90%). Purified total CD4+ Tresp cells (1 × 105) were co-cultured with CD4+CD25+ Tregs (5 × 104), 
APCs (1 × 105) and 1 µg/ml anti-CD3 antibody (Clone 145-2C11; R&D Systems) for 72 hours in U-bottom 
96-well plate. Bromodeoxyuridine (BrdU) was added to the co-culture at 48 hours. Cell proliferation was meas-
ured using the BrdU proliferation kit (Millipore) according to manufacturer’s instructions. Proliferation of 
CD3-stimulated Tresp cells without adding Tregs was considered as baseline proliferation with 0% suppression. 
Percent suppression was calculated using the following formula: % suppression = [(Tresp proliferation without 
Tregs − Tresp proliferation with Tregs)/Tresp proliferation without Tregs] × 100.
Cell sorting and adoptive transfer. For adoptive transfer experiments, cells were isolated from cervi-
cal and submandibular draining lymph nodes and the spleen. These tissues were harvested from room air or 
DED graft recipients (as indicated), and single cell suspensions were prepared. For isolation of Foxp3+ lineage 
cells and exFoxp3 cells, we used Foxp3-GFP-Cre-R26-RFP double transgenic mice, and collected the draining 
lymph nodes and spleen to prepare single cell suspensions. Cells were sorted using the BD FACS Aria II sorter 
at Harvard Stem Cell Institute and The Regenerative Medicine FACS core facility. To sort the subpopulation of 
tTreg (CD4+CD25+Nrp-1+) and pTreg (CD4+CD25+Nrp-1−), Nrp-1 staining was performed prior to sorting, in 
combination with CD4 and CD25 staining as indicated in some experiments. The expression of Foxp3 by sorted 
tTregs and pTregs was confirmed using flow cytometry (purity >90%). For adoptive transfer experiments, 1 × 105 
Treg cells/ml were injected to the tail vein of room air or DED recipients.
Conjunctival and lymph node explant culture with PMA and ionomycin stimulation. For ex 
vivo explant cultures, tissues were harvested 14 days post-transplantation from DED or control hosts. The con-
junctiva and all ipsilateral draining lymph nodes were dissected carefully using a pair of sterile vannas scissors 
and micro-forceps under the surgical microscope. Dissected tissues were then placed in U-bottom 96-well plate 
in RPMI-100 complete media with additional PMA and Ionomycin for 24 hours; supernatant from each well was 
collected and analyzed using ELISA.
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Enzyme-linked immunosorbent assay (ELISA). The supernatant of the tissue explant culture was 
kept frozen at −80 °C until used for ELISA. ELISA detection kits for murine IL-6 and IL-23 (BMS603HS and 
BMS6017, eBiosciences) were used according to the manufacturer’s instructions. Absorbance was determined 
using a POLARstar Optima plate reader (BMG Labtech).
Statistical analyses. Experiments with more than two groups were analyzed via one-way or two-way anal-
ysis of variance (ANOVA) test with post-hoc Tukey’s or Bonferroni’s multiple comparison test. Comparisons 
between two groups were analyzed using the Student’s t-test. A P value of < 0.05 was considered statistically 
significant. All data are expressed as mean ± SEM. Results are representative of at least three independent exper-
iments. All statistical calculations were performed using Prism Version 5.04 software (GraphPad).
Data availability. All data generated or analyzed during this study are included in this published article.
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